{
  "id": 6276012,
  "title": "Novartis stock sinks toward worst day ever after third drug trial failure in a week",
  "url": "https://urgent.news/2026/09/08/novartis-stock-sinks-toward-worst-day-ever-after-third-drug-trial",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T11:40:36.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/novartis-del-desiran-trial-failure-stock-090826"
  },
  "original_language": "en",
  "account": null,
  "summary": "The HARBOR study failure is Novartis's second major late-stage trial setback in days and its third pipeline blow in a week",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}